<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=utf-8">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
	{font-family:"Calibri Light";
	panose-1:2 15 3 2 2 2 4 3 2 4;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:0cm;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
h1
	{mso-style-link:"Heading 1 Char";
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	line-height:107%;
	page-break-after:avoid;
	font-size:16.0pt;
	font-family:"Calibri Light",sans-serif;
	color:#2F5496;
	font-weight:normal;}
h2
	{mso-style-link:"Heading 2 Char";
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	line-height:107%;
	page-break-after:avoid;
	font-size:13.0pt;
	font-family:"Calibri Light",sans-serif;
	color:#2F5496;
	font-weight:normal;}
h3
	{mso-style-link:"Heading 3 Char";
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	line-height:107%;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Calibri Light",sans-serif;
	color:#1F3763;
	font-weight:normal;}
a:link, span.MsoHyperlink
	{color:#0563C1;
	text-decoration:underline;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:36.0pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:36.0pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
span.Heading1Char
	{mso-style-name:"Heading 1 Char";
	mso-style-link:"Heading 1";
	font-family:"Calibri Light",sans-serif;
	color:#2F5496;}
span.Heading3Char
	{mso-style-name:"Heading 3 Char";
	mso-style-link:"Heading 3";
	font-family:"Calibri Light",sans-serif;
	color:#1F3763;}
span.Heading2Char
	{mso-style-name:"Heading 2 Char";
	mso-style-link:"Heading 2";
	font-family:"Calibri Light",sans-serif;
	color:#2F5496;}
.MsoChpDefault
	{font-family:"Calibri",sans-serif;}
.MsoPapDefault
	{margin-bottom:8.0pt;
	line-height:107%;}
@page WordSection1
	{size:595.3pt 841.9pt;
	margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style>

</head>

<body lang=EN-AU link="#0563C1" vlink="#954F72" style='word-wrap:break-word'>

<div class=WordSection1>

<h1><span lang=EN-US style='font-size:15.0pt;line-height:107%'>2021A02 Describe
the individual effects of propofol and sevoflurane on the cerebral metabolic
rate of oxygen consumption (CMRO<sub>2</sub>) and cerebral blood flow (CBF).</span></h1>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>&nbsp;</span></p>

<h3><span lang=EN-US style='font-size:13.0pt;line-height:107%'>Sevoflurane:</span></h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=114 valign=top style='width:85.25pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>CMRO<sub>2</sub> vs MAC</span></p>
  </td>
  <td width=487 valign=top style='width:365.55pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.55pt;text-indent:-9.0pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>Dose-dependent reduction in
  electrophysiological function (60% of total)</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.55pt;text-indent:-9.0pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>No effect on basal function (40% of total) –
  only reduced by hypothermia</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US><img width=204 height=199 id="Picture 5"
  src="2021A02_propofol_sevoflurane_neurophysiology_files/image001.jpg"
  alt="Diagram&#10;&#10;Description automatically generated"></span></p>
  <p class=MsoListParagraph style='margin-top:0cm;margin-right:0cm;margin-bottom:
  0cm;margin-left:12.55pt;text-indent:-9.0pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><i><span lang=EN-US>Exponential decay -&gt; greater effect at
  low dose</span></i></p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=114 valign=top style='width:85.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>CBF vs CMRO<sub>2</sub></span></p>
  </td>
  <td width=487 valign=top style='width:365.55pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.55pt;text-indent:-9.0pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>Dose-dependent vasodilatation (↓L-Ca<sup>2+</sup>
  activity, ↑NO activity)</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.55pt;text-indent:-9.0pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>Coupling of CBF and CMRO<sub>2</sub> impaired
  (not ablated)</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US><img width=202 height=191 id="Picture 2"
  src="2021A02_propofol_sevoflurane_neurophysiology_files/image002.jpg"></span></p>
  <p class=MsoListParagraph style='margin-top:0cm;margin-right:0cm;margin-bottom:
  0cm;margin-left:12.55pt;text-indent:-9.0pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><i><span lang=EN-US>Slope </span></i><span lang=EN-GB
  style='font-family:"Cambria Math",serif;color:#202124;background:white'>∝ </span><i><span
  lang=EN-US>dose -&gt; greater effect at high dose</span></i></p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>&nbsp;</span></p>
  </td>
 </tr>
 <tr>
  <td width=114 valign=top style='width:85.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>CBF vs MAC<span style='color:red'>*</span></span></p>
  </td>
  <td width=487 valign=top style='width:365.55pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.55pt;text-indent:-9.0pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>At low concentration: indirect
  vasoconstriction (via ↓CMRO<sub>2</sub>) wins</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.55pt;text-indent:-9.0pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>At high concentration: direct vasodilatation
  wins</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US><img width=196 height=192 id="Picture 6"
  src="2021A02_propofol_sevoflurane_neurophysiology_files/image003.jpg"></span></p>
  </td>
 </tr>
 <tr>
  <td width=114 valign=top style='width:85.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Other</span></p>
  </td>
  <td width=487 valign=top style='width:365.55pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.55pt;text-indent:-9.0pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>Luxury perfusion: due to ↓CMRO<sub>2</sub> but
  ↑CBF</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.55pt;text-indent:-9.0pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>Hypoventilation: ↑PaCO<sub>2</sub> may cause
  further vasodilatation (if spont vent)</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>&nbsp;</span></p>

<h2><span lang=EN-US>Propofol:</span></h2>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=114 valign=top style='width:85.25pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>CMRO2 vs Ce</span></p>
  </td>
  <td width=487 valign=top style='width:365.55pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraph style='margin-top:0cm;margin-right:0cm;margin-bottom:
  0cm;margin-left:12.55pt;text-indent:-9.0pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>Same as for sevoflurane</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US><img width=219 height=204 id="Picture 3"
  src="2021A02_propofol_sevoflurane_neurophysiology_files/image004.jpg"></span></p>
  </td>
 </tr>
 <tr>
  <td width=114 valign=top style='width:85.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>CMRO2 vs CBF</span></p>
  </td>
  <td width=487 valign=top style='width:365.55pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraph style='margin-top:0cm;margin-right:0cm;margin-bottom:
  0cm;margin-left:12.55pt;text-indent:-9.0pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>Coupling of CBF and CMRO<sub>2</sub>
  unaffected</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US><img width=222 height=176 id="Picture 4"
  src="2021A02_propofol_sevoflurane_neurophysiology_files/image005.jpg"></span></p>
  </td>
 </tr>
 <tr>
  <td width=114 valign=top style='width:85.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>CBF vs Ce</span></p>
  </td>
  <td width=487 valign=top style='width:365.55pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.55pt;text-indent:-9.0pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>Dose-dependent ↓CBF (ideal agent in
  intracranial hypertension)</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.55pt;text-indent:-9.0pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>Note exponential decay</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US><img width=180 height=168 id="Picture 8"
  src="2021A02_propofol_sevoflurane_neurophysiology_files/image006.jpg"></span></p>
  </td>
 </tr>
 <tr>
  <td width=114 valign=top style='width:85.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  lang=EN-US>Other</span></p>
  </td>
  <td width=487 valign=top style='width:365.55pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:12.55pt;text-indent:-9.0pt;line-height:normal'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span><span lang=EN-US>↑↑Propofol Ce -&gt; ↓SVR -&gt; ↓mAP -&gt;
  ↓perfusion</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-bottom:0cm;text-indent:-18.0pt;
  line-height:normal'><span lang=EN-US style='font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
  lang=EN-US>Autoregulation exhausted if mAP &lt;50mmHg</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>Feedback welcome
at ketaminenightmares@gmail.com</span></p>

<div style='border:none;border-bottom:solid windowtext 1.0pt;padding:0cm 0cm 1.0pt 0cm'>

<p class=MsoNormal style='margin-bottom:0cm;border:none;padding:0cm'><span
lang=EN-US>&nbsp;</span></p>

</div>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<h2><span lang=EN-GB style='color:red'>*</span><span lang=EN-GB>Addendum</span></h2>

<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-GB style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>This graph is from Miller’s Anesthesia, Chapter
11</span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-GB style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The data are from Anesthesiology (<a
href="https://pubmed.ncbi.nlm.nih.gov/3740503/">https://pubmed.ncbi.nlm.nih.gov/3740503/</a>)</span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-GB style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>At 0.5 MAC, mean values for local blood flow
were reduced in every grey matter tissue</span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-GB style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>However, none of the individual changes was
statistically significant due to a large standard deviation</span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-GB style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>My personal opinion is:</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;text-indent:-18.0pt'><span
lang=EN-GB style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-GB>It is unlikely that a universal decrement in
mean blood flow between 0 MAC and 0.5 MAC was due to chance</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;text-indent:-18.0pt'><span
lang=EN-GB style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-GB>Statistical significance would have been reached
had sample sizes been larger</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;text-indent:-18.0pt'><span
lang=EN-GB style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-GB>These findings are consistent with the curves
for CBF vs CMRO<sub>2</sub> and CMRO<sub>2</sub> vs MAC</span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-GB style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-GB>The alternative opinion is:</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;text-indent:-18.0pt'><span
lang=EN-GB style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-GB>There is no evidence for significant change in
CBF between 0 MAC and 1 MAC</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;text-indent:-18.0pt'><span
lang=EN-GB style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-GB>In this range, the indirect vasoconstriction
(via ↓CMRO<sub>2</sub>) and the direct vasodilation roughly cancel each other
out</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;text-indent:-18.0pt'><span
lang=EN-GB style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-GB>This is consistent with the leftward/upward
shift in the CBF vs mAP curve that occurs with any concentration of volatile
anaesthetic</span></p>

<p class=MsoListParagraphCxSpLast style='margin-left:72.0pt;text-indent:-18.0pt'><span
lang=EN-GB style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-GB>See the Eger-Stoelting version below:</span></p>

<p class=MsoNormal><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:18.0pt;text-indent:36.0pt'><span
lang=EN-GB><img border=0 width=350 height=242 id="Picture 1"
src="2021A02_propofol_sevoflurane_neurophysiology_files/image007.png"></span></p>

<p class=MsoNormal style='text-indent:36.0pt'><span lang=EN-GB>&nbsp;</span></p>

<p class=MsoNormal><span lang=EN-GB>Special thanks to Dr. Stan Tay for his
insights.</span></p>

<p class=MsoNormal style='margin-bottom:0cm'><span lang=EN-US>&nbsp;</span></p>

</div>

</body>

</html>
